RxDoctor Payments Data

Kamariah Baker

Medical · Reno, NVNPI 1093296741

Payments from drug & device makers

$2,927in general payments, 2019–2025

Across 126 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$529
  • AbbVie$513
  • Merz Pharmaceuticals, LLC$177
  • Vertos Medical, Inc.$169
  • Relievant Medsystems, Inc.$139
  • Vanda Pharmaceuticals Inc.$134
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$2,927100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,927 in reported general payments places this provider in the 75th percentile of 250 medical providers in Nevada.

See all medical providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin21$16,985
TradjentaLinagliptin14$12,118
Wixela InhubFluticasone Propion/Salmeterol13$2,197
Albuterol Sulfate HfaAlbuterol Sulfate37$1,285
Ondansetron Hcl23$814
Ventolin HfaAlbuterol Sulfate11$531
Gabapentin35$469
Rosuvastatin Calcium21$443
Omeprazole25$283
Montelukast Sodium21$243
Hydroxyzine Hcl13$240
Lisinopril38$239
Fluticasone Propionate15$226
Atorvastatin Calcium47$224
Levothyroxine Sodium29$220

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$41$29,10335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 250 medical providers in Nevada.

Other medical in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →